Bruce Cozadd, chief executive of Jazz Pharmaceuticals. Photograph: Dara Mac Dónaill / The Irish Times

Dublin-based Jazz Pharmaceuticals said revenues rose 15 per cent in the second quarter of the year as sales of its Xyrem product increased. The compa(...)

Jazz Pharmaceuticals CEO and chairman Bruce Cozadd, with Taoiseach Enda Kenny. Photograph:  Shane O’Neill / Fennells.

Shares in Jazz Pharma dropped over 7 per cent yesterday in US trade as the market digested results that came in slightly below expectations for(...)

An Taoiseach Enda Kenny and Bruce Cozadd, chairman and chief executive of Jazz Pharmaceuticals plc, in  Monksland, Athlone, Co Roscommon, on Monday.

Jazz Pharmaceuticals is investing €50 million on a new manufacturing plant outside Athlone, Co Roscommon, that will create 50 high-skilled full-time j(...)

Jazz Pharmaceuticals, the Dublin-based maker of the narcolepsy treatment Xyrem, is buying Italian rare disease drug developer Gentium in a $1 billion (...)

Investors in pharmaceuticals businesses are a nervous bunch as Bruce Cozadd and his team at Dublin-based Jazz Pharmaceuticals discovered this w(...)